The Damouni Group Announces Launch of Strategic Communications and Corporate Affairs Agency

TAMPA, Fla.--(BUSINESS WIRE)--Aug 6, 2024--

The Damouni Group, LLC (“Damouni Group”), a strategic communications and corporate affairs agency dedicated to the life sciences sector, announced its launch today. Under the leadership of founder Sasha Damouni Ellis, a seasoned media and investor relations expert, Damouni Group will establish a new standard for impactful and results-driven communications across key stakeholder audiences.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240806799548/en/

Founding Partner, Sasha Damouni Ellis (Photo: Business Wire)

“Over the last decade, I’ve witnessed communications evolve into a more cross-functional role, emphasizing shared metrics beyond traditional publicity and media relations. It is increasingly important to integrate investor, patient, policy, and other stakeholder perspectives into the overall storytelling strategy, particularly in early to mid-stage life science companies,” said Sasha Damouni Ellis, Founding Partner of Damouni Group. “We’re excited to establish an advisory agency which offers a corporate affairs perspective that empowers clients to navigate the dynamic healthcare landscape throughout every step of a company’s life cycle.”

Damouni Group builds on Sasha Damouni Ellis’s 20+ years of experience as a healthcare journalist and corporate communications officer. She provides guidance on stakeholder engagement, narrative development, and measurable outcomes to drive business success. Ms. Damouni Ellis has previously served as Chief Corporate Affairs Officer at Vir Biotechnology, an immunology-focused company, and as Senior Vice President of Corporate Affairs and Investor Relations at Marinus Pharmaceuticals, specializing in rare seizure disorders. She also led external communications and media relations at Bayer U.S., executing brand-building campaigns in oncology, hemophilia, cardio-pulmonary, and women’s health. Earlier in her career, Ms. Damouni Ellis was a Healthcare Journalist at Bloomberg News and Global Editor of BioPharm Insight (Pharmawire), formerly a division of the Financial Times Group, which she launched in New York and London.

With a commitment to excellence, Damouni Group leverages a network of experts and providers to deliver a comprehensive suite of services, including issues and crisis management, restructuring and litigation, as well as creative marketing and branding. This approach ensures effective program management, operational efficiency, and strategic counsel for its clients.

About Damouni Group

Damouni Group launched in 2024, as a full-service strategic communications and corporate affairs firm for the healthcare and life science sector. The Company’s Founding Partner has over 20 years of media and investor relations experience, providing clients with the resources to build and protect their reputations during key events, including product launches, regulatory approvals, M&A, crisis and change management, as well as driving patient advocacy and public policy engagement. Damouni Group has a network of partners that support product communications, branding, and marketing. For more information, please visit www.damounigroup.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20240806799548/en/

CONTACT: info@damounigroup.com

KEYWORD: UNITED STATES NORTH AMERICA FLORIDA

INDUSTRY KEYWORD: OTHER COMMUNICATIONS CONSULTING PUBLIC RELATIONS/INVESTOR RELATIONS COMMUNICATIONS PROFESSIONAL SERVICES BIOTECHNOLOGY HEALTH OTHER SCIENCE SCIENCE

SOURCE: The Damouni Group, LLC

PUB: 08/06/2024 08:10 AM/DISC: 08/06/2024 08:10 AM

http://www.businesswire.com/news/home/20240806799548/en